EmbryoTrans Biotech ApS: Financial statements 2019
CVR: 36701676
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,319,977 and a net result of DKK 23,111 compared with DKK -17,779 the year before. That is an increase of 16.2% compared with the year before. Equity in the 2019 report amounted to DKK 252,733. The solvency ratio was 50.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,319,977
- Profit/Loss
- DKK 23,111
- Equity
- DKK 252,733
- Total Assets
- DKK 498,023
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.3 mio. | 23 t. | 253 t. | 2 |
| 2018 | - | 1.1 mio. | -18 t. | 260 t. | - |
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
EmbryoTrans Biotech ApS has published its annual report for 2018. Gross profit came to DKK 1,135,620, and the net result was DKK -17,779.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company was previously named BioLife BioTech ApS. The company has 1 employee (2021). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.